Stephen Mayo, Director at Sarepta Therapeutics, Inc. (SRPT), sold 6,270 shares at $122.96 ($771K) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Open-market sale of $771k SRPT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.96 | 3,135 | $385K | 50.0% |
| 2 | $122.96 | 3,135 | $385K | 50.0% |
| Total | $122.96 avg | 6,270 | $771K | 100% |
| Filing → |
| SRPT | SELL | 2022-11-21 | $189K | — | Filing → |